Evergen

About Evergen

Evergen is a Contract Development and Manufacturing Organization (CDMO) in the field of regenerative medicine. Founded in 1998, the company develops and manufactures customized biomaterial solutions based on allograft and xenograft materials for Original Equipment Manufacturers (OEMs). The biomaterials support the body's natural healing process and are used in a wide range of clinical applications. Evergen always starts from patient needs and selects the appropriate biomaterials for individual surgical requirements. Clinical specialties include plastic and reconstructive surgery, sports medicine and orthopedics, neuro/spine, and cardiac surgery. According to the company, more than 20 million implants have been shipped since its founding, along with over 200 Market Authorizations and more than 50 510(k)-Clearances achieved. The company sees itself as a partner-oriented development and manufacturing service provider with a patient focus.

Processes

Development and manufacturing of regenerative biomaterial solutions (CDMO), Contract Development and Manufacturing (CDMO), Development and manufacturing of customized regenerative biomaterial solutions, Design, Development and Manufacturing for OEMs, Donor Services

Materials

Allograft biomaterials, Xenograft biomaterials

Founded

1998

Industries

Regenerative Medicine, Medical Technology, Plastic and Reconstructive Surgery, Sports Medicine and Orthopedics, Neuro/Spine, Cardiac Surgery

1. 01

   Identification of patient needs

2. 02

   Design and development (Design, Development & Manufacturing for OEMs)

3. 03

   Manufacturing of customized allograft/xenograft biomaterials

4. 04

   Delivery to OEMs worldwide

Biomaterials

Processes & technical limits

History

1. 1998

   Foundation of the company

2. Achievement of over 20 million implants shipped, more than 200 Market Authorizations and over 50 510(k)-Clearances